openPR Logo
Press release

Neurological Disorder Diagnostics Market Industry Insights, Size and Forecast To 2025 | Masimo Corporation, Esaote SpA, Siemens Healthineers

Neurological Disorder Diagnostics, Neurological Disorder Diagnostics market, Neurological Disorder Diagnostics market Size

Neurological Disorder Diagnostics, Neurological Disorder Diagnostics market, Neurological Disorder Diagnostics market Size

A detailed study on 'Neurological Disorder Diagnostics Market' formulated by Brandessence Market Research, puts together a concise analysis of the growth factors impacting the current business scenario across assorted regions. Significant information pertaining to the industry's size, share, application, and statistics are also summed in the report in order to present an ensemble prediction. In addition, this report undertakes an accurate competitive analysis illustrating the status of market majors in the projection timeline, while including their expansion strategies and portfolio.

Some of the major and emerging players in the Global Neurological Disorder Diagnostics Market are Koninklijke Philips N.V., Masimo Corporation, Esaote SpA, Siemens Healthineers

Get Sample Copy of this Premium Report @ https://industrystatsreport.com/Request/Sample?ResearchPostId=258&RequestType=Sample

The Players Profiled in the Report:
Koninklijke Philips N.V., Masimo Corporation, Esaote SpA, Siemens Healthineers

Neurological Disorder Diagnostics Market is valued around USD 11305.69 Million in 2018 and expected to reach USD 18273.57 Million by 2025 with the CAGR of 7.1% over the forecast period. Increased prevalence of neurological disorders and increase in technological advancements are the key drivers for Global Neurological Disorder Diagnostics Market.

Neurological disorder diagnostics are the various medical devices used for the diagnosis of various neurological disorders such as Parkinson's disease, Alzheimer's disease and others. These medical devices include various imaging devices such as CT Scan, Magnetic resonance Imaging, biopsy and others. Increasing prevalence of these disorders has led to the increased demand for better diagnostics and better treatment over the period of time.

There are various factors driving the growth of the neurological disorder diagnostics market, one of the major factors expected to drive the growth of this market is increase in the prevalence of neurological disorders and others coupled with increased awareness among people over the period of time. As per Alzheimer's Association 2018 report, there were around 5.7million of Americans living with Alzheimer's dementia in 2018 which includes an estimated 5.5 million people age 65 and older and approximately 200,000 individuals under age 65 who have younger-onset Alzheimer's. Furthermore, various collaborations among major market players are also expected to promote the growth of neurological disorder diagnostics over the forecast period. Moreover, increase in various technological advancements for the development of novel diagnostics are anticipated to fuel drive the growth of market. However, high costs of these medical devices are expected to hinder the growth of neurological disorder diagnostics market.

The report includes the forecasts, Analysis and discussion of important industry trends, market size, market share estimates and profiles of the leading industry Players.

Neurological Disorder Diagnostics Market Segmentation -

By Disorder Type
Genetic Neurological Disorders
Immunological Neurological Disorders
Paraneoplastic Syndrome
Paraproteinemic Neuropathies
Others

By Technology Type
Imaging
In Vitro Diagnostics

By End-User
Hospitals
Ambulatory Surgical Centers
Diagnostics Centers
Others

Methodology of this Premium Report @
https://industrystatsreport.com/Request/Sample?ResearchPostId=258&RequestType=Methodology

Regional Analysis for Neurological Disorder Diagnostics Market:

North America Country (United States, Canada), South America, Asia Country (China, Japan, India, Korea), Europe Country (Germany, UK, France, Italy), Other Country (Middle East, Africa, GCC)

The report size market by 5 major regions, known as, North America, Europe, Asia Pacific (includes Asia & Oceania separately), Middle East and Africa (MEA), and Latin America and further into 15+ country level break-up that includes China, the UK, Germany, United States, France, Japan, batch of Southeast Asian & Nordic countries.

The Neurological Disorder Diagnostics market factors described in this report are:

Key Strategic Developments in Neurological Disorder Diagnostics Market:

The research includes the key strategic activities such as Research & Development (R&D) initiatives, Merger & Acquisition (M&A) completed, agreements, new launches, collaborations, partnerships & (JV) Joint ventures, and regional growth of the key competitors operating in the market at global and regional scale.

Key Market Features in Global Neurological Disorder Diagnostics Market:

The report highlights Neurological Disorder Diagnostics market features, including revenue size, weighted average regional price, capacity utilization rate, production rate, gross margins, consumption, import & export, demand & supply, cost bench-marking in Neurological Disorder Diagnostics, market share and annualized growth rate (Y-o-Y) and Periodic CAGR.

1. Chapter - Report Methodology
1.1. Research Process
1.2. Primary Research
1.3. Secondary Research
1.4. Market Size Estimates
1.5. Data Triangulation
1.6. Forecast Model
1.7. USP's of Report
1.8. Report Description

2. Chapter - Global Neurological Disorder Diagnostics Market Overview: Qualitative Analysis
2.1. Market Introduction
2.2. Executive Summary
2.3. Global Neurological Disorder Diagnostics Market Classification
2.4. Market Drivers
2.5. Market Restraints
2.6. Market Opportunity
2.7. Neurological Disorder Diagnostics Market: Trends

3. Chapter - Global Neurological Disorder Diagnostics Market Overview: Quantitative Analysis
3.1. Global Neurological Disorder Diagnostics Market Consumption, Market Share ( %) and Growth Rate, 2015-2025
3.2. Global Neurological Disorder Diagnostics Market Revenue (USD Million), Market Share (%) and Growth Rate (%), 2015-2025

Full Report @ https://industrystatsreport.com/Lifesciences-and-Healthcare/Neurological-Disorder-Diagnostics-Market/Summary

About Us:
We publish market research reports & business insights produced by highly qualified and experienced industry analysts. Our research reports are available in a wide range of industry verticals including aviation, food & beverage, healthcare, ICT, Construction, Chemicals and lot more. Brand Essence Market Research report will be best fit for senior executives, business development managers, marketing managers, consultants, CEOs, CIOs, COOs, and Directors, governments, agencies, organizations and Ph.D. Students.

Contact US:
Brandessence Market Research & Consulting Pvt ltd.,
Kemp House, 152 - 160 City Road, London EC1V 2NX
+44-2038074155
sales@brandessenceresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Neurological Disorder Diagnostics Market Industry Insights, Size and Forecast To 2025 | Masimo Corporation, Esaote SpA, Siemens Healthineers here

News-ID: 1998063 • Views:

More Releases from Brandessence Market Research & Consulting Pvt ltd.

Neuroscience Antibodies and Assays Market Scenario, Gross Margin, Future Trends, …
Market Overview: Global Neuroscience Antibodies and Assays Market to reach USD 5.1 billion by 2025 Global Neuroscience Antibodies and Assays Market valued approximately USD 2.1 billion in 2016 is anticipated to grow with a healthy growth rate of more than 10.3% over the forecast period 2017-2025. The increasing automation of high-throughput screening and the availability of robust data management software tools, which enable researchers to develop systemic and process-oriented approaches toward neuroscience
Atomic Layer Deposition (ALD) Market Revenue, Top Players, Impact Analysis, Upco …
Market Overview: Global Atomic Layer Deposition (ALD) Market to reach USD 3.1 billion by 2025 Global Atomic Layer Deposition (ALD) Market valued approximately USD 1.1 billion in 2016 is anticipated to grow with a healthy growth rate of more than 12.04% over the forecast period 2017-2025. Increasing need for miniaturized components and Nano-technology, advancement in electronic sectors, increasing concern for global warming and emergence of new technologies like dye-sensitized solar cells, are
Diabetic Neuropathy Market Share, Company Profiles, Future Demand, Opportunities …
Market Overview: Global Diabetic Neuropathy Market to reach USD 8460.3 million by 2025. Global Diabetic Neuropathy Market valued approximately USD 4680 million in 2016 is anticipated to grow with a healthy growth rate of more than 6.80% over the forecast period 2017-2025. The growth of this market primarily driven by the ever-growing pool of geriatric population with diabetes. The rise in availability of suitable treatment options and the growing awareness on PDN
Circulating Tumor Cells (CTC) Market Global Trends, COVID-19 Impact Analysis, Co …
Market Overview: Global Circulating Tumor Cells (CTC) Market to reach USD 22.5 billion by 2025 Global Circulating Tumor Cells (CTC) Market valued approximately USD 5 billion in 2016 is anticipated to grow with a healthy growth rate of more than 18.20% over the forecast period 2017-2025. Circulating tumor cells are significantly useful in determining the status of disease progression rate and projection of therapy needed for tumor eradication. Further development of various

All 5 Releases


More Releases for Neurological

Neurological Disorder Drugs Market - Forecasts to 2027
According to a new market research report published by Global Market Estimates, the Global Neurological Disorder Drugs Market is projected to grow at a CAGR value of 5.6% from 2022 to 2027. The rising cases of neurodegenerative diseases such as dementia and Alzheimer's disease, a susceptible aging population, and an increase in research and development projects by numerous pharmaceutical companies are factors fueling market growth during the forecast period. Pfizer Inc,
Neurological Biomarkers Market 2021 | Detailed Report
ReportsnReports publishes the report titled Neurological Biomarkers that presents a 360-degree overview of the market under one roof. The report is developed with the meticulous efforts of an enthusiastic and experienced team of experts, analyts, and researchers that makes the report a valuable asset for stakeholders to make robust decisions. This report also provides an in-depth overview of product type, specification, technology, and production analysis considering vital factors like cost,
Global Neurological Biomarkers Market - Forecast to 2026
The findings reviewed by GME stated that the Global Neurological Biomarkers Market would grow at a CAGR value of 10.2 percent from 2021 to 2026. Today, with advancing technology and neurological applications, the awareness about the effectiveness of biomarker signature in diagnosing diseases or disorders is also increasing. Besides the beneficial features attributed to the neurological biomarkers, the annual exponential increase in the rate of neurological diseases is also accelerating
7th International Conference on Neurological Disorders & Stroke
Greetings from Stroke Congress 2018!! We are writing to request all your presence to our CME accredited event as our eminent Speaker for the upcoming “7th International Conference on Neurological Disorders & Stroke (Stroke Congress 2018)” scheduled to be held on September 20-21, 2018 in Rome, Italy. The theme of the conference is Melioration in Innovations with advancement in Neurological disorders and Stroke to create awareness on the current needs &
Neurological Biomarkers Market Competition Insights 2025
Global Neurological Biomarkers Market: Overview This report on the global neurological biomarkers market is a comprehensive market intelligence study that brings forth the lucrativeness of the said market. Beginning with an executive summary that comprise a snapshot of how the demand for neurological biomarkers has evolved over the recent past and where is it headed to in the future, the report delves into the analysis of various market dynamics, such as
Neurological Biomarkers Market: Pipeline Overview 2017 - 2025
Biomarkers are biological markers which measure the biological states. It is used for indicating the normal biological and pathogenic process to a therapeutic intervention. These biomarkers can also be used in combination to access disease state of an individual. Scientists are exploring more about the structural and functional differences of the neurological diseases. Moreover, there has been an increase in biobanks which have help address unmet needs in oncology, neuroscience,